Trial Profile
Phase III trial investigating the efficacy and safety of buspirone/testosterone [Lybridos] for the treatment of hypoactive sexual desire disorder
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 21 Apr 2015
Price :
$35
*
At a glance
- Drugs Buspirone/testosterone (Primary)
- Indications Female sexual dysfunction
- Focus Registrational; Therapeutic Use
- 17 Apr 2015 This trial is expected to be initiated in 2015, according to an Emotional Brain media release.
- 11 Mar 2014 New trial record